Pacira BioSciences (PCRX) Return on Capital Employed (2011 - 2026)

Pacira BioSciences' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 2.14% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 888.0% year-over-year to 2.14%; the TTM figure through Mar 2026 stood at 2.14% (up 888.0% YoY), while the FY2025 annual figure was 1.49%, up 734.0% from the prior year.
• Return on Capital Employed was 2.14% for Q1 2026 at Pacira BioSciences, up from 1.65% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.0% in Q1 2024 to a low of 8.35% in Q2 2025.
• Historically, Return on Capital Employed has averaged 1.63% across 5 years, with a median of 3.17% in 2025.
• The sharpest annual moves came in 2025 and 2026: Return on Capital Employed sank 1442 bps in 2025, then surged 888 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 3.85% in 2022, then soared by 56 bps to 6.02% in 2023, then plunged by 199 bps to 5.98% in 2024, then jumped by 128 bps to 1.65% in 2025, then rose by 29 bps to 2.14% in 2026.
• The last three Return on Capital Employed figures came in at 2.14% (Q1 2026), 1.65% (Q4 2025), and 3.17% (Q3 2025), per Business Quant data.